---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-129170"
form_type: "8-K"
ticker: "KYMR"
cik: "0001815442"
company_name: "Kymera Therapeutics, Inc."
filed_at: "2026-03-27T23:59:59+00:00"
generated_at: "2026-05-15T08:40:37.907559+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Kymera Therapeutics amends bylaws to designate federal courts for securities claims

## Summary
- Board approved amendment to Second Amended and Restated Bylaws on March 25, 2026.
- Federal district courts designated exclusive forum for claims under Securities Act of 1933 and Exchange Act of 1934.
- Amendment effective immediately; company may consent to alternative forum in writing.
- Change made in response to recent amendments to Delaware General Corporation Law.

## SEC filing metadata
- accession: 0001193125-26-129170
- form_type: 8-K
- ticker: KYMR
- cik: 0001815442
- company_name: Kymera Therapeutics, Inc.
- filed_at: 2026-03-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815442/000119312526129170/0001193125-26-129170-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815442/000119312526129170/d122194d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-129170
- JSON: https://secwatch.observer/filing/0001193125-26-129170.json
- Plain text: https://secwatch.observer/filing/0001193125-26-129170.txt

## Source-grounded claims
- claim_id: 6754406f86add6aa7f6bad4c28e28c66c7c2a2b6
  claim: Kymera Therapeutics, Inc.: Amended bylaws to designate federal district courts as exclusive forum for Securities Act and Exchange Act claims (effective 2026-03-25).
  evidence_excerpt: On March 25, 2026, the Board of Directors (the “Board”) of Kymera Therapeutics, Inc. (the “Company”) approved an amendment to the Company’s Second Amended and Restated Bylaws (the “Bylaw Amendment”), effective immediately, to designate the federal district courts of the United States as the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, or the respective rules and regulations promulgated thereunder, unless the Company consents in writing to the selection of an alternative forum.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1815442/000119312526129170/0001193125-26-129170-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.